✦ LIBER ✦

Guidelines for the Quality Control of Population Pharmacokinetic–Pharmacodynamic Analyses: an Industry Perspective

✍ Scribed by Bonate, P. L.; Strougo, A.; Desai, A.; Roy, M.; Yassen, A.; Walt, J. S.; Kaibara, A.; Tannenbaum, S.

Book ID: 118062854
Publisher: American Association of Pharmaceutical Scientists
Year: 2012
Tongue: English
Weight: 278 KB
Volume: 14
Category: Article
ISSN: 1550-7416
DOI: 10.1208/s12248-012-9387-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacodynamic and pharmacokinetic rati

Pharmacodynamic and pharmacokinetic rationales for the development of an oral controlled-release amoxicillin dosage form

✍ Amnon Hoffman; Haim D Danenberg; Ifat Katzhendler; Rivka Shuval; Dalia Gilhar; M 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 153 KB

An industry perspective on the monitorin

An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics

✍ Satish K. Singh; Nataliya Afonina; Michel Awwad; Karoline Bechtold-Peters; Jeffr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 1 views

Concern around the lack of monitoring of proteinaceous subvisible particulates in the 0.1-10 mm range has been heightened (Carpenter et al., 2009, J Pharm Sci 98: 1202-1205), primarily due to uncertainty around the potential immunogenicity risk from these particles. This article, representing the op

Is It Ethical to Conduct Placebo-Control

Is It Ethical to Conduct Placebo-Controlled Clinical Trials in the Development of New Agents for Osteoporosis? An Industry Perspective

✍ Michael Rosenblatt 📂 Article 📅 2003 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 32 KB